Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | OT-82 |
Synonyms | |
Therapy Description |
OT-82 inhibits nicotinamide phosphoribosyltransferase (NAMPT), which results in a decrease in the level of NAD, potentially leading to decreased tumor growth (PMID: 31896781). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
OT-82 | OT82|OT 82 | NAMPT Inhibitor 7 | OT-82 inhibits nicotinamide phosphoribosyltransferase (NAMPT), which results in a decrease in the level of NAD, potentially leading to decreased tumor growth (PMID: 31896781). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03921879 | Phase I | OT-82 | Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma | Unknown status | USA | 0 |